Related News

FDA Approves Keytruda for Advanced NSCLC

Oct 5, 2015

Approved for use with PD-L1 IHC 22C3 pharmDx test

Palliative Radiotherapy Often Overused in Stage IV NSCLC

Oct 5, 2015

Not proven to further improve symptoms or quality of life; can have significant side effects

FDA Approves New Combo Therapy for Melanoma

Oct 5, 2015

Yervoy and Opdivo previously approved individually to treat melanoma

Frequently Asked Questions